LinkedIn
ALOOSTA
Contact
The approval period for 40 active substances was extended in Commission Implementing Regulation (EU) 2023/918 of 4.5.23 amending EU Regulation 540/2011. It is valid from 8.5.23.
For the majority of the active substances, the authorisation would have expired shortly. The processing of the applications by the Commission requires more time, which is why the extension of the authorisation became necessary. We limit ourselves in the presentation to the chemical active substances.
|
Active ingredient |
Approval until |
Reference |
|
Aclonifen |
31.10.2026 |
1) |
|
Ametoctradin |
31.12.2025 |
|
|
Beflubutamid |
31.10.2026 |
|
|
Benthiavalicarb |
15.11.2024 |
|
|
Boscalid |
15.04.2026 |
|
|
Captan |
15.11.2024 |
|
|
Clethodim |
31.08.2026 |
|
|
Cycloxydim |
31.08.2026 |
|
|
Cyflumetofen |
31.10.2025 |
|
|
Dazomet |
31.08.2026 |
|
|
Diclofop |
31.08.2026 |
|
|
Dimethomorph |
15.02.2025 |
|
|
Ethephon |
15.11.2024 |
|
|
Fenazaquin |
31.08.2026 |
|
|
Fluopicolide |
31.08.2026 |
|
|
Fluoxastrobin |
15.06.2025 |
|
|
Flurochloridone |
15.03.2026 |
|
|
Folpet |
15.02.2025 |
|
|
Formetanate |
15.02.2025 |
|
|
Hymexazol |
31.08.2026 |
|
|
Indolylbutyric acid |
15.03.2026 |
|
|
Mandipropamid |
31.12.2025 |
|
|
Metalaxyl |
30.09.2026 |
|
|
Metaldehyde |
31.08.2026 |
|
|
Metam |
30.11.2025 |
|
|
Metazachlor |
31.10.2026 |
|
|
Metribuzin |
15.02.2025 |
|
|
Milbemectin |
15.02.2025 |
|
|
Paclobutrazol |
31.08.2026 |
|
|
Penoxsulam |
15.05.2026 |
|
|
Phenmedipham |
15.02.2025 |
|
|
Pirimiphos-methyl |
15.06.2025 |
|
|
Propamocarb |
15.06.2025 |
|
|
Proquinazid |
15.05.2026 |
|
|
Prothioconazole |
15.08.2025 |
|
|
S-Metolachlor |
15.11.2024 |
Author: Dr. Frank Mörsberger
Contact
Career